GFA
8783
Pixel
2743
Chiome Bioscience
4583
Pluszero
5132
Silver Egg Technology
3961
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -40.10%1.73B | 53.23%4.53B | -234.31%-4.67B | 406.85%2.37B | -157.80%-500M | -2.79%2.9B | -35.32%2.96B | 52.14%-1.4B | -53.62%467M | 176.36%865M |
Net profit before non-cash adjustment | 25.32%2.94B | 2.81%1.02B | 118.36%1.01B | 17.39%243M | -2.81%658M | 16.23%2.34B | -38.12%995M | 143.68%463M | 179.62%207M | 41.93%677M |
Total adjustment of non-cash items | 215.84%863M | 20,050.00%806M | -214.42%-1.64B | 450.90%1.37B | 97.53%320M | -148.47%-745M | -99.71%4M | 25.50%-520M | -215.68%-391M | -68.48%162M |
-Depreciation and amortization | -1.14%521M | -6.43%131M | -1.49%132M | 0.78%130M | 3.23%128M | -8.98%527M | -11.95%140M | -4.96%134M | -6.52%129M | -12.06%124M |
-Reversal of impairment losses recognized in profit and loss | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
-Disposal profit | -435.71%-47M | -107.14%-1M | ---46M | ---- | ---- | 101.65%14M | 101.69%14M | --0 | ---- | ---- |
-Other non-cash items | 130.25%389M | 550.67%676M | -163.15%-1.72B | 338.85%1.24B | 405.26%192M | -171.48%-1.29B | -107.32%-150M | 20.15%-654M | -365.31%-520M | -89.81%38M |
Changes in working capital | -259.66%-2.07B | 37.88%2.7B | -201.79%-4.04B | 15.87%752M | -6,012.00%-1.48B | 325.44%1.29B | 23.91%1.96B | 44.37%-1.34B | -29.99%649M | 103.70%25M |
-Change in receivables | -780.91%-4.64B | -28.58%3.24B | 7.95%-4.47B | -293.94%-1.98B | -5,833.33%-1.42B | 139.82%681M | 81.96%4.54B | 0.57%-4.86B | 150.12%1.02B | -108.86%-24M |
-Change in inventory | -281.64%-554M | -14.84%1.23B | 24.74%-359M | -69.82%-1.69B | -20.66%265M | -60.65%305M | -39.28%1.44B | -854.00%-477M | 34.22%-994M | 956.41%334M |
-Change in payables | 805.93%3.21B | 54.91%-1.85B | -76.95%954M | 811.85%4.23B | 9.42%-125M | -27.31%354M | -19.13%-4.11B | 54.29%4.14B | -75.09%464M | 77.30%-138M |
-Provision for loans, leases and other losses | -172.00%-36M | -23.85%99M | -24.80%-156M | 17.24%204M | -41.86%-183M | 184.75%50M | -28.57%130M | 9.42%-125M | -4.92%174M | 54.90%-129M |
-Changes in other current assets | 52.08%-46M | 65.85%-14M | 47.37%-10M | 38.89%-11M | 38.89%-11M | -43.28%-96M | -105.00%-41M | -11.76%-19M | -5.88%-18M | -38.46%-18M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 11.43%-31M | 0.00%-8M | 12.50%-7M | 12.50%-7M | 18.18%-9M | 37.50%-35M | 33.33%-8M | 42.86%-8M | 42.86%-8M | 31.25%-11M |
Interest received (cash flow from operating activities) | 12.50%81M | -14.29%6M | 17.24%34M | 22.22%11M | 11.11%30M | -2.70%72M | 0.00%7M | 7.41%29M | -25.00%9M | -3.57%27M |
Tax refund paid | -7.92%-818M | 51.43%53M | -98.15%-428M | 66.67%-17M | 19.01%-426M | 9.22%-758M | 128.93%35M | -8.00%-216M | -200.00%-51M | 6.90%-526M |
Other operating cash inflow (outflow) | 0.00%-1M | -1M | 2M | -2M | 0 | 0.00%-1M | 0 | 0 | 0 | -1M |
Operating cash flow | -55.59%965M | 53.16%4.58B | -218.42%-5.07B | 464.03%2.35B | -355.65%-905M | 0.60%2.17B | -32.71%2.99B | 48.74%-1.59B | -60.51%417M | 247.50%354M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -11.03%-151M | -371.43%-33M | -85.00%-37M | 68.42%-30M | -264.29%-51M | -691.30%-136M | -101.23%-7M | 66.67%-20M | -400.00%-95M | 96.99%-14M |
Net intangibles purchase and sale | 65.65%-45M | 94.74%-2M | -320.00%-21M | 63.46%-19M | 91.67%-3M | 20.61%-131M | -52.00%-38M | 80.00%-5M | -550.00%-52M | 66.36%-36M |
Net investment product transactions | 363.41%108M | 42.86%-4M | 1,130.77%134M | -9.09%-12M | 0.00%-10M | -1,466.67%-41M | 0.00%-7M | -140.63%-13M | 8.33%-11M | 0.00%-10M |
Net changes in other investments | --207M | --206M | --2M | --0 | ---1M | ---- | ---- | ---- | ---- | ---- |
Investing cash flow | 138.64%119M | 415.09%167M | 310.81%78M | 61.39%-61M | -8.33%-65M | -91.30%-308M | -113.42%-53M | 30.19%-37M | -354.84%-158M | 89.38%-60M |
Financing cash flow | ||||||||||
Net issuance payments of debt | 56.35%-790M | -50.32%-4.75B | 175.14%5.09B | -582.86%-2.39B | 940.00%1.26B | 0.00%-1.81B | 38.64%-3.16B | -48.32%1.85B | 71.07%-350M | -115.46%-150M |
Net common stock issuance | --0 | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Increase or decrease of lease financing | -36.36%-15M | -33.33%-4M | -33.33%-4M | 0.00%-3M | -100.00%-4M | 8.33%-11M | 0.00%-3M | -50.00%-3M | 0.00%-3M | 50.00%-2M |
Cash dividends paid | -5.83%-218M | --0 | --0 | 0.00%-8M | -6.06%-210M | 0.00%-206M | --0 | --0 | 0.00%-8M | 0.00%-198M |
Net other fund-raising expenses | ---1M | --1M | ---1M | --1M | -100.00%-2M | ---- | ---- | --0 | --0 | 0.00%-1M |
Financing cash flow | 49.48%-1.02B | -50.32%-4.75B | 175.31%5.09B | -564.82%-2.4B | 397.44%1.04B | 0.10%-2.03B | 38.63%-3.16B | -48.35%1.85B | 70.41%-361M | -145.76%-351M |
Net cash flow | ||||||||||
Beginning cash position | -64.03%91M | -51.28%152M | -40.43%56M | -16.33%164M | -64.03%91M | -11.23%253M | -44.58%312M | -35.17%94M | -20.33%196M | -11.23%253M |
Current changes in cash | 137.04%60M | 99.10%-2M | -55.71%97M | -6.86%-109M | 229.82%74M | -440.00%-162M | 28.16%-222M | -47.73%219M | 0.00%-102M | -50.00%-57M |
Cash adjustments other than cash changes | --1M | --2M | ---- | ---- | ---1M | ---- | ---- | ---- | ---- | ---- |
End cash Position | 67.03%152M | 67.03%152M | -51.28%152M | -40.43%56M | -16.33%164M | -64.03%91M | -64.03%91M | -44.58%312M | -35.17%94M | -20.33%196M |
Free cash flow | -59.65%769M | 54.31%4.55B | -217.08%-5.12B | 752.96%2.3B | -415.46%-959M | 33.57%1.91B | -33.05%2.95B | 49.33%-1.62B | -73.74%270M | 137.30%304M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |